
Beijing Tiantan Biological Products Investor Relations Material
Latest events

Q1 2025
15 Apr, 2025

H2 2024
28 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Beijing Tiantan Biological Products Co Ltd
Access all reports
Beijing Tiantan Biological Products Co., Ltd. is a biopharmaceutical company that develops, manufactures, and distributes a range of blood-based and vaccine products. The company focuses on producing plasma-derived products, including treatments for immune deficiencies and blood coagulation disorders, as well as vaccines for infectious diseases. Utilizing advanced bioprocessing and quality assurance standards, Beijing Tiantan Biological aims to support healthcare needs in China and potentially in international markets. The company is involved in research to expand its product portfolio within the biologics field. Beijing Tiantan Biological Products is headquartered in Beijing, China, and its shares are listed on the Shanghai Stock Exchange.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
600161
Country
🇨🇳 China